newsfilter
← Latest News
PR Newswire·

LumiraDx CRP Test Achieves CE Marking

LONDON, Jan. 11, 2022 /PRNewswire/ -- LumiraDx (NASDAQ:LMDX), a next-generation point of care diagnostics company, today announced its C-reactive protein (CRP) Test has achieved CE Marking. The LumiraDx CRP Test is a small, portable, fully automated, mic